MedTrace Logo

Cardiopulmonary Rehabilitation in COVID-19 Longhaulers

NCT04898205 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-05-25

No results posted yet for this study

Summary

This study will test the efficacy of treadmill exercise combined with supplemental oxygen during exercise and recovery for the treatment of persistent post-acute COVID-19 symptoms. Participants will be pseudo-randomized (stratified by age) to one of four conditions for 8 treatment sessions: 1) treadmill exercise plus supplemental oxygen, 2) treadmill exercise plus air, 3) supplemental oxygen only, 4) air only. All participants will then cross-over and receive 16 additional sessions of treadmill exercise plus supplemental oxygen.

Conditions

  • Covid19
  • Viral Syndrome

Interventions

OTHER

Treadmill Exercise

The cardiopulmonary rehabilitation protocol utilizes progressive treadmill exercise with alternating increases in intensity and incline with no more than 0.5 Met increase per session.

OTHER

Concentrated Oxygen

Supplemental oxygen from a concentrator (6 liters per minute) will be provided via nasal cannula regardless of oxygen saturation.

OTHER

Concentrated Air

Room air will be delivered through an concentrator provided via nasal cannula.

Sponsors & Collaborators

  • University of Dayton

    collaborator OTHER

  • Noah Greenspan

    lead OTHER

Principal Investigators

  • Noah Greenspan, DPT · Pulmonary Wellness Foundation

  • Julie Walsh-Messinger, Ph.D. · University of Dayton

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-21
Primary Completion
2022-01-20
Completion
2022-01-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04898205 on ClinicalTrials.gov